Merger changes—not the old Q - Clinical Research Associate IQVIA Employee Review

3.0
Dec 18, 2017
Recommend
CEO approval
Business Outlook

Pros

Per diem for billable projects in the CRA role (makes up for slightly below average salary) decent 401k matching, discretionary vacation for all employees, work from home flexibility, educated workforce, exciting projects, and lots of opportunities for advancement and movement within the company

Cons

Reduction in benefits following the IMS-Quintiles merger; health plans are costlier and not as robust, no longer reimbursed for gym memberships, and below industry average salaries

Explore other reviews about IQVIA

5.0
Jul 9, 2026
Recommend
CEO approval
Business Outlook

Pros

- Great people - Interesting industry - Great leaders

Cons

- Shifting industry so not their fault but budgets came down after COVID for research

4.0
Jul 8, 2026
Recommend
CEO approval
Business Outlook

Pros

Great company culture, excellent team support, fantastic management at all levels. I especially value the training initiatives that help in the day to day. This is a great place to build skills, especially in AI. Work life balance is emphasized and encouraged.

Cons

It can feel a bit like being a cog in the wheel at times, although good ideas do get the attention of management. Workload can be unrelenting around EOQ. Process "improvement" initiatives are constant, poorly announced, and often make things worse. Raises and bonuses are meager and do not keep up with inflation/market value.

See reviews by: Helpful|Rating|Date|All